<DOC>
	<DOCNO>NCT00736801</DOCNO>
	<brief_summary>BDNF link pathogenesis airway hyperresponsiveness asthma . In trial , impact treatment salmeterol salmeterol / fluticasone BDNF concentration assess patient asthma . The investigator hypothesize salmeterol impact BDNF concentration patient asthma .</brief_summary>
	<brief_title>Effect Salmeterol Brain-Derived Neurotrophic Factor ( BDNF ) Concentrations Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Age &gt; 18 year , physician 's diagnosis allergic asthma A documented sensitization aeroallergens ( pollen , animal hair , house dust mite ) A prebronchodilator forced expiratory volume first second ( FEV1 ) &gt; 80 % predict value ( % predict ) , provocative concentration histamine cause 20 % fall FEV1 ( PC20 ) &lt; 8 mg histamine / ml No regular treatment ( shortacting inhaler demand allow ) No history evidence chronic disease asthma No history smoking , absence sign symptom infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Airway hyperresponsiveness</keyword>
</DOC>